NCT01055249 is a Phase 1 clinical trial of Ibuprofen, Hydrocortisone in Pain, sponsored by X-pert Med GmbH.

Who is sponsoring NCT01055249?

NCT01055249 is sponsored by X-pert Med GmbH.

What drugs are being tested in NCT01055249?

Interventions in NCT01055249: Ibuprofen, Hydrocortisone, Hydrocortisone.

What condition does NCT01055249 study?

NCT01055249 studies Pain, Inflammation, Healthy Volunteers.

Is NCT01055249 still recruiting?

NCT01055249 is currently completed. Last updated 12 July 2010.

Last reviewed 2010-07-12 · How we verify

NCT01055249

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Single Centre, Subject and Observer Blinded, Placebo Controlled, Cross-over Study of the Effect of Oral Ibuprofen and Topical Hydrocortisone-21-acetate on Ultraviolet Radiation (UVR) Induced Pain and Inflammation in Healthy Volunteers

Completed Phase 1 Last updated 12 July 2010

What this trial tests

Phase 1 trial testing Ibuprofen, Hydrocortisone in Pain in 24 participants. Completed.

Timeline

1 January 2010

Primary endpoint
1 June 2010

Quick facts

Lead sponsor	X-pert Med GmbH
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	basic science
Enrollment	24
Start date	1 January 2010
Primary completion	1 June 2010
Sites	1 location across Germany

Drugs / interventions tested

Ibuprofen, Hydrocortisone — full drug profile →
Hydrocortisone (hydrocortisone) — full drug profile →

Conditions studied

Pain — all drugs for Pain →
Inflammation — all drugs for Inflammation →
Healthy Volunteers — all drugs for Healthy Volunteers →

Sponsor

X-pert Med GmbH — full company profile →

Who can join

Adults 18 to 55, any sex, with Pain or Inflammation. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Hyperalgesia to heat
Time frame: 72 h

Sponsor's own description

Single centre, subject and observer blinded, placebo controlled, cross-over study of the effect of oral ibuprofen and topical hydrocortisone-21-acetate on ultraviolet radiation (UVR) induced pain and inflammation in healthy volunteers conducted in two segments and using an intra-individual comparison of application areas.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01055249 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by X-pert Med GmbH
Last refreshed: 12 July 2010

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01055249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing